Cargando…

Regulation of AKT gene expression by cisplatin

The use of chemotherapy drugs for the treatment of cancer is an effective therapeutic measure. However, chemoresistance affects the effectiveness of the treatment. AKT overexpression has been observed in chemoresistance. AKT expression in colon cells induced cisplatin resistance. The present study d...

Descripción completa

Detalles Bibliográficos
Autores principales:	ZHANG, JUN, ZHANG, LING-LI, SHEN, LEI, XU, XI-MING, YU, HONG-GANG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576191/ https://www.ncbi.nlm.nih.gov/pubmed/23426872 http://dx.doi.org/10.3892/ol.2013.1132

Ejemplares similares

Cordycepin augments the chemosensitivity of osteosarcoma to cisplatin by activating AMPK and suppressing the AKT signaling pathway
por: Li, Hong-Bo, et al.
Publicado: (2021)

Knockdown of Akt Sensitizes Osteosarcoma Cells to Apoptosis Induced by Cisplatin Treatment
por: Zhang, Guoyou, et al.
Publicado: (2011)

MiR-200c regulates tumor growth and chemosensitivity to cisplatin in osteosarcoma by targeting AKT2
por: Liu, Yang, et al.
Publicado: (2017)

Regulation of MicroRNA-497-Targeting AKT2 Influences Tumor Growth and Chemoresistance to Cisplatin in Lung Cancer
por: Wang, Lin, et al.
Publicado: (2020)

Corrigendum: Regulation of microrna-497-targeting AKT2 influences tumor growth and chemoresistance to cisplatin in lung cancer
por: Wang, Lin, et al.
Publicado: (2022)

Downregulated expression levels of USP46 promote the resistance of ovarian cancer to cisplatin and are regulated by PUM2
por: Xu, Lei, et al.
Publicado: (2021)

Linalool Prevents Cisplatin Induced Muscle Atrophy by Regulating IGF-1/Akt/FoxO Pathway
por: Zhang, Hong, et al.
Publicado: (2020)

Regulation of apoptosis-inducing factor-mediated, cisplatin-induced apoptosis by Akt
por: Yang, X, et al.
Publicado: (2008)

Smad3 Sensitizes Hepatocelluar Carcinoma Cells to Cisplatin by Repressing Phosphorylation of AKT
por: Zhou, Hong-Hao, et al.
Publicado: (2016)

Inhibitor of DNA binding 3 reverses cisplatin resistance in human lung adenocarcinoma cells by regulating the PI3K/Akt pathway
por: Chen, Fang-Fang, et al.
Publicado: (2018)

Knockdown of RAP2A gene expression suppresses cisplatin resistance in gastric cancer cells
por: Zhang, Jinyu, et al.
Publicado: (2020)

Interleukin-22 modulates cisplatin sensitivity of osteosarcoma cells by regulating the STAT3 signaling pathway
por: Li, Zhiqiang, et al.
Publicado: (2020)

The protective effects of maltol on cisplatin-induced nephrotoxicity through the AMPK-mediated PI3K/Akt and p53 signaling pathways
por: Mi, Xiao-jie, et al.
Publicado: (2018)

PINK1 regulates apoptosis of osteosarcoma as the target gene of cisplatin
por: Si, Zhenxing, et al.
Publicado: (2023)

Antisense transcription regulates the expression of sense gene via alternative polyadenylation
por: Shen, Ting, et al.
Publicado: (2017)

Cordycepin Reverses Cisplatin Resistance in Non-small Cell Lung Cancer by Activating AMPK and Inhibiting AKT Signaling Pathway
por: Liao, Xiao-Zhong, et al.
Publicado: (2021)

Sky1 regulates the expression of sulfur metabolism genes in response to cisplatin
por: Rodríguez-Lombardero, Silvia, et al.
Publicado: (2014)

Tanshinone IIA combined with cisplatin synergistically inhibits non‐small‐cell lung cancer in vitro and in vivo via down‐regulating the phosphatidylinositol 3‐kinase/Akt signalling pathway
por: Liao, Xiao‐Zhong, et al.
Publicado: (2019)

Long non-coding RNA MEG3 promotes cisplatin-induced nephrotoxicity through regulating AKT/TSC/mTOR-mediated autophagy
por: Jing, Xu, et al.
Publicado: (2021)

Akt1 regulates pulmonary fibrosis via modulating IL-13 expression in macrophages
por: Nie, Yunjuan, et al.
Publicado: (2019)

Piperlongumine Inhibits Akt Phosphorylation to Reverse Resistance to Cisplatin in Human Non-Small Cell Lung Cancer Cells via ROS Regulation
por: Zhang, Chao, et al.
Publicado: (2019)

Inhibition of KDM5A attenuates cisplatin-induced hearing loss via regulation of the MAPK/AKT pathway
por: Liu, Chang, et al.
Publicado: (2022)

MiR-29c reduces the cisplatin resistance of non-small cell lung cancer cells by negatively regulating the PI3K/Akt pathway
por: Sun, Dian-min, et al.
Publicado: (2018)

Abnormally elevated USP37 expression in breast cancer stem cells regulates stemness, epithelial-mesenchymal transition and cisplatin sensitivity
por: Qin, Tao, et al.
Publicado: (2018)

LncRNA MALAT1 Regulates the Cell Proliferation and Cisplatin Resistance in Gastric Cancer via PI3K/AKT Pathway
por: Dai, Qingqiang, et al.
Publicado: (2020)

Esomeprazole Alleviates Cisplatin Resistance by Inhibiting the AKT/mTOR Pathway in Ovarian Cancer Cells
por: Duan, Jingya, et al.
Publicado: (2023)

Shenmai Injection Supresses Glycolysis and Enhances Cisplatin Cytotoxicity in Cisplatin-Resistant A549/DDP Cells via the AKT-mTOR-c-Myc Signaling Pathway
por: Sun, Ye, et al.
Publicado: (2020)

AKT isoforms have discrete expression in triple negative breast cancers and roles in cisplatin sensitivity
por: Wadhwa, Bhumika, et al.
Publicado: (2020)

Metadherin Regulation of Vascular Endothelial Growth Factor Expression Is Dependent Upon the PI3K/Akt Pathway in Squamous Cell Carcinoma of the Head and Neck
por: Zhu, Gang-cai, et al.
Publicado: (2015)

Correction to: Abnormally elevated USP37 expression in breast cancer stem cells regulates stemness, epithelial-mesenchymal transition and cisplatin sensitivity
por: Qin, Tao, et al.
Publicado: (2021)

Expression of AKT and p-AKT protein in lung adenocarcinoma and its correlation with PD-L1 protein and prognosis
por: Hu, Zhi-Ying, et al.
Publicado: (2020)

Ubiquitin-specific peptidase 17 promotes cisplatin resistance via PI3K/AKT activation in non-small cell lung cancer
por: Zhang, Shengchao, et al.
Publicado: (2020)

The involvement of Bcl-2 family proteins in AKT-regulated cell survival in cisplatin resistant epithelial ovarian cancer
por: Dai, Yan, et al.
Publicado: (2016)

A Strategy to Delay the Development of Cisplatin Resistance by Maintaining a Certain Amount of Cisplatin-Sensitive Cells
por: Duan, Guihua, et al.
Publicado: (2017)

Concurrent cisplatin and 5-fluorouracil versus concurrent cisplatin and docetaxel with radiotherapy for esophageal squamous cell carcinoma: a propensity score-matched analysis
por: Zhang, Peng, et al.
Publicado: (2016)

The deacetylation of Foxk2 by Sirt1 reduces chemosensitivity to cisplatin
por: Wang, Xi‐wen, et al.
Publicado: (2021)

Histone H4 expression is cooperatively maintained by IKKβ and Akt1 which attenuates cisplatin-induced apoptosis through the DNA-PK/RIP1/IAPs signaling cascade
por: Wang, Ruixue, et al.
Publicado: (2017)

PI3K/AKT signaling pathway as a critical regulator of Cisplatin response in tumor cells
por: NAVAEI, ZAHRA NASRPOUR, et al.
Publicado: (2022)

NT-3 promotes osteogenic differentiation of mouse bone marrow mesenchymal stem cells by regulating the Akt pathway
por: Zhang, Shanqiang, et al.
Publicado: (2020)

MNAT1 promotes proliferation and the chemo-resistance of osteosarcoma cell to cisplatin through regulating PI3K/Akt/mTOR pathway
por: Qiu, Chensheng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3mnur1emkfrdeo0q2snfdqs978